We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Reducing Polypharmacy: Is Hospitalization the Right Time?

Ryan Borne, MD; Ethan Cumbler, MD; Jeffrey J. Glasheen, MD
Arch Intern Med. 2011;171(9):869-870. doi:10.1001/archinternmed.2011.208.
Text Size: A A A
Published online


In their study examining the feasibility of discontinuing medications in elderly patients, Garfinkel and Mangin1 were able to successfully stop nearly half of community-dwelling patients' medication therapies. Surprisingly, at follow-up 88% of patients reported overall improvement.

The authors propose an evidence-based, step-wise approach to evaluating medication regimens that has now proven effective in clinic and nursing home environments. We believe it would be interesting to extend this tool to the hospital setting. Hospitalization presents an opportune point of intervention where long-term medication management decisions could be addressed as part of the comprehensive review of medications and their indications inherent in the medication reconciliation process. Up to 1 in 5 patients discharged from the hospital have an adverse event, the majority of which are related to medications.2 The likelihood of medication discrepancies and adverse drug events is closely related to the total number of medications a patient is taking.3,4 In addition, hospitalization has the potential to provide time for patient education about medications and discussion of how high-risk medications affect a patient's goals of care. Hospital discharge offers a natural break point for the application of this type of tool to reduce rather than expand a patient's medication list.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

2 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Care at the Close of Life: Evidence and Experience
Polypharmacy and Drug-Drug Interactions